Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rachael Coleman
Patient-Specific Factors Modulate Leukocyte Response in Dimethyl Fumarate Treated MS Patients
PLoS ONE
Multidisciplinary
Related publications
Nonfatal PML in a Patient With Multiple Sclerosis Treated With Dimethyl Fumarate
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Pnd117 - Physician Reported Adherence in Ms Patients Treated With Injectable Platform Therapies Versus Delayed-Release Dimethyl Fumarate: Findings From a Real-World Cross-Sectional Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd79 - Reduced Healthcare Resource Utilisation for Patients Treated With Delayed Release Dimethyl Fumarate vs Injectable Therapies: Findings From a Real-World Cross-Sectional Study of Ms Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
B-Cell Composition in the Blood and Cerebrospinal Fluid of Multiple Sclerosis Patients Treated With Dimethyl Fumarate
Multiple Sclerosis and Related Disorders
Medicine
Neurology
Japanese Guidelines for Dimethyl Fumarate
Clinical and Experimental Neuroimmunology
Neuroscience
Neurology
Immunology
Microbiology
Dimethyl Fumarate in the Management of Multiple Sclerosis: Appropriate Patient Selection and Special Considerations
Therapeutics and Clinical Risk Management
Dimethyl Fumarate for Relapsingremitting Multiple Sclerosis
Prescriber
Pharmacology
Factors That Influence Response Classifications in Chemotherapy Treated Patient-Derived Xenografts (PDX)
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Effect of Dimethyl Fumarate on Lymphocytes in RRMS
Neurology
Neurology
